- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cutaneous T-cell Lymphoma in New Zealand
Total 1525 results
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
New York Medical CollegeRecruitingT-cell Acute Lymphoblastic Leukemia | T-Cell Acute Lymphoblastic LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterOhio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.CompletedT-cell Lymphoma | Relapsed and Refractory T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Canada, France, Italy, Belgium
-
New York Medical CollegeUniversity of Alabama at BirminghamRecruitingPeripheral T Cell Lymphoma | NK-Cell Lymphoma | NK-Cell LeukemiaUnited States
-
Yaupon TherapeuticsCompletedMycosis FungoidesUnited States
-
Rhizen Pharmaceuticals SACompleted
-
Washington University School of MedicineCompletedLeukemia-Lymphoma, Adult T-CellUnited States
-
Seagen Inc.TerminatedHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
Yale UniversityKyowa Kirin, Inc.Not yet recruitingT Cell LymphomaUnited States
-
Yaupon TherapeuticsCompletedMycosis FungoidesUnited States
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma...Active, not recruiting
-
Astex Pharmaceuticals, Inc.Active, not recruitingRelapsed/Refractory Peripheral T-cell LymphomaSpain, United States, Australia, France, United Kingdom, Italy, Poland
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
Bristol-Myers SquibbCompletedLymphoblastic Leukemia, Acute T-cell | Precursor T-Cell Lymphoblastic LymphomaUnited States, France, Germany
-
National Cancer Institute (NCI)Active, not recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic LymphomaUnited States, Canada, Australia, New Zealand, Switzerland
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Kura Oncology, Inc.CompletedRelapsed or Refractory Peripheral T-Cell LymphomaUnited States, Spain, Korea, Republic of
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.RecruitingMycosis Fungoides | Sezary Syndrome | Lymphomatoid PapulosisUnited States
-
CerRx, Inc.UnknownPeripheral T-cell LymphomaUnited States
-
SanofiTerminatedT-cell Type Acute Leukemia-Precursor | T-lymphoblastic Lymphoma/LeukaemiaHungary, United States, Finland, France, Italy, Lithuania, Russian Federation
-
Children's Oncology GroupActive, not recruitingLymphoblastic Lymphoma | Acute Leukemia | Recurrent Disease | T-cell Lymphoma | Leukemia, Lymphocytic | T-cell LeukemiaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Terminated
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
Ryan WilcoxUniversity of Michigan Rogel Cancer Center; TakedaActive, not recruitingLymphoma, T-Cell, PeripheralUnited States
-
Rigel PharmaceuticalsCompletedT Cell LymphomaUnited States, Canada
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumGlaxoSmithKline; NovartisTerminatedRelapsed T-Cell Acute Lymphoblastic Leukemia | Relapsed T-Cell Lymphoblastic LymphomaUnited States, France, Canada, Australia, Austria, Italy, Netherlands
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; University of Washington; H. Lee...Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingSezary Syndrome | Refractory T-Cell Non-Hodgkin Lymphoma | Merkel Cell Carcinoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extramammary Paget Disease | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin... and other conditionsUnited States
-
Ono Pharmaceutical Co. LtdRecruitingRelapsed or Refractory T Cell LymphomaUnited States
-
Seagen Inc.Active, not recruitingPeripheral T-cell LymphomaUnited States, Czechia, Italy, Spain, United Kingdom, France
-
Memorial Sloan Kettering Cancer CenterRecruitingMycosis Fungoides | Sezary Syndrome | Mycosis Fungoides/Sezary Syndrome | Sézary | Advanced Mycosis FungoidesUnited States
-
Aileron Therapeutics, Inc.CompletedLymphoma | Solid Tumor | Peripheral T-Cell LymphomaUnited States
-
Roswell Park Cancer InstituteCompletedPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma and other conditionsUnited States
-
SecuraBioCompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Germany, Italy
-
Emergent Product Development Seattle LLCTerminatedMycosis Fungoides | Sezary SyndromeUnited States, Spain, France, Germany, Italy
-
Stanford UniversityRecruitingNon-Hodgkin's Lymphoma | Mycosis FungoidesUnited States, China, Argentina, Australia, Brazil, Japan, United Kingdom
-
CelgeneCompletedPeripheral T-cell LymphomaUnited States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
Eisai Inc.CompletedLymphoma, T-Cell, PeripheralUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
Corvus Pharmaceuticals, Inc.Active, not recruitingT-cell LymphomaUnited States, China, Australia, Korea, Republic of
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
Eli Lilly and CompanyCompletedT-cell Acute Lymphoblastic Leukemia | T-cell Lymphoblastic LymphomaUnited States, Germany, Israel, France, Italy
-
Spectrum Pharmaceuticals, IncOnxeoCompletedPeripheral T-cell LymphomaUnited States, Belgium, United Kingdom, Germany, Spain, Poland, Israel, Netherlands, Canada, Croatia, Denmark, France, Hungary, Italy, Russian Federation, Slovakia, South Africa